Rhee CK et al. |
Effects of platelet activating factor on vascular permeability of the middle ear mucosa. |
1997 |
Ann. Otol. Rhinol. Laryngol. |
pmid:9228864
|
Rhee CK et al. |
Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10335705
|
Jeon SY et al. |
Rat model of platelet-activating factor-induced rhinosinusitis. |
2005 |
Ann. Otol. Rhinol. Laryngol. |
pmid:15966528
|
Jeon SY et al. |
Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. |
2001 |
Ann. Otol. Rhinol. Laryngol. |
pmid:11201815
|
Kim DH et al. |
Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. |
2006 |
Ann. Otol. Rhinol. Laryngol. |
pmid:16944661
|
Jeon SY et al. |
Ultrastructural changes in platelet activating factor-induced epithelial damage in rabbit maxillary sinus mucosa. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10961804
|
Ohno Y et al. |
Effects of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig. |
1998 |
Ann. Otol. Rhinol. Laryngol. |
pmid:9794619
|
Price JE et al. |
In vitro platelet aggregability studies: lack of evidence for platelet hyperactivity in systemic sclerosis. |
1991 |
Ann. Rheum. Dis. |
pmid:1888199
|
Hilliquin P et al. |
Presence of paf-acether in rheumatic diseases. |
1992 |
Ann. Rheum. Dis. |
pmid:1540032
|
Herrero-Beaumont G and Egido J |
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage. |
1997 |
Ann. Rheum. Dis. |
pmid:9165991
|
Hilliquin P et al. |
Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730. |
1995 |
Ann. Rheum. Dis. |
pmid:7702404
|
Eggleton P et al. |
Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. |
1995 |
Ann. Rheum. Dis. |
pmid:7492242
|
Kaminski DL et al. |
The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor. |
1990 |
Ann. Surg. |
pmid:2171443
|
Fletcher JR et al. |
Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. |
1990 |
Ann. Surg. |
pmid:2178565
|
Yamakawa Y et al. |
Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. |
2000 |
Ann. Surg. |
pmid:10714632
|
Heinrich S et al. |
Evidence-based treatment of acute pancreatitis: a look at established paradigms. |
2006 |
Ann. Surg. |
pmid:16432347
|
Spitzer AL et al. |
Applying Ockham's razor to pancreatitis prognostication: a four-variable predictive model. |
2006 |
Ann. Surg. |
pmid:16495704
|
Ontell SJ et al. |
Pharmacologic modulation of experimental postischemic hepatic function. |
1989 |
Ann. Surg. |
pmid:2916864
|
Makowka L et al. |
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. |
1987 |
Ann. Surg. |
pmid:3310931
|
Unno N et al. |
Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. |
2002 |
Ann. Surg. |
pmid:11807372
|
Nathan N and Denizot Y |
Platelet-activating factor antagonist and cardiopulmonary bypass. |
1995 |
Ann. Thorac. Surg. |
pmid:7677525
|
Zehr KJ et al. |
Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. |
1995 |
Ann. Thorac. Surg. |
pmid:7847945
|
Taggart DP |
Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation. |
2001 |
Ann. Thorac. Surg. |
pmid:11216754
|
Qayumi AK et al. |
The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury. |
1998 |
Ann. Thorac. Surg. |
pmid:9647083
|
Kim JD et al. |
Platelet activating factor acetylhydrolase decreases lung reperfusion injury. |
2000 |
Ann. Thorac. Surg. |
pmid:10969656
|
Corcoran PC et al. |
Reduction of conjugated dienes in lung transplantation: effect of BN 52021. |
1993 |
Ann. Thorac. Surg. |
pmid:8267425
|
Qayumi AK et al. |
Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation. |
1991 |
Ann. Thorac. Surg. |
pmid:1929620
|
Nathan N and Denizot Y |
Tumor necrosis factor and platelet-activating factor during cardiopulmonary bypass. |
1993 |
Ann. Thorac. Surg. |
pmid:8494455
|
Zhang J et al. |
Strategies of myocardial protection for operation in chronic model of cyanotic heart disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9875743
|
Hanahan DJ |
Platelet activating factor: a biologically active phosphoglyceride. |
1986 |
Annu. Rev. Biochem. |
pmid:3017194
|
Prescott SM et al. |
Platelet-activating factor and related lipid mediators. |
2000 |
Annu. Rev. Biochem. |
pmid:10966465
|
Larsen GL and Henson PM |
Mediators of inflammation. |
1983 |
Annu. Rev. Immunol. |
pmid:6399978
|
Parker CW |
Lipid mediators produced through the lipoxygenase pathway. |
1987 |
Annu. Rev. Immunol. |
pmid:3036183
|
Bach MK |
Mediators of anaphylaxis and inflammation. |
1982 |
Annu. Rev. Microbiol. |
pmid:6128957
|
Saunders RN and Handley DA |
Platelet-activating factor antagonists. |
1987 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:3555317
|
Feuerstein G and Hallenbeck JM |
Prostaglandins, leukotrienes, and platelet-activating factor in shock. |
1987 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:3034139
|
Vanhoutte PM et al. |
Modulation of vascular smooth muscle contraction by the endothelium. |
1986 |
Annu. Rev. Physiol. |
pmid:2871807
|
Semini G et al. |
Glycosidated phospholipids - a promising group of anti-tumour lipids. |
2014 |
Anticancer Agents Med Chem |
pmid:24628240
|
Zimmermann A and Keller H |
Shape changes and chemokinesis of Walker carcinosarcoma cells: effects of protein kinase inhibitors (HA-1004, polymyxin B, sangivamycin and tamoxifen) and an inhibitor of diacylglycerol kinase (R 59022). |
1993 Mar-Apr |
Anticancer Res. |
pmid:8390801
|
Adamson LM et al. |
Release of anti-PAF activity from PAF-binding human ovarian cancer cells in culture. |
1992 Mar-Apr |
Anticancer Res. |
pmid:1580546
|
Berdel WE et al. |
Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. |
1987 Nov-Dec |
Anticancer Res. |
pmid:3442414
|
Torley LW et al. |
Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416889
|
Nunn B et al. |
Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers. |
1985 |
Antimicrob. Agents Chemother. |
pmid:4015075
|
Lang F et al. |
Mechanisms and significance of eryptosis. |
2006 Jul-Aug |
Antioxid. Redox Signal. |
pmid:16910766
|
Cao YZ et al. |
Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. |
2001 |
Antioxid. Redox Signal. |
pmid:11813988
|
Kamaladasa A et al. |
Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators. |
2016 |
Antiviral Res. |
pmid:27476044
|
Chamogeorgakis TP et al. |
Effect of N-acetyl-L-cysteine on lung ischaemia reperfusion injury in a porcine experimental model. |
2008 Jan-Feb |
ANZ J Surg |
pmid:18199211
|
Steel HC et al. |
Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. |
2002 |
APMIS |
pmid:12064871
|
Ginesta MM et al. |
Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model. |
2003 |
APMIS |
pmid:12752216
|
Marrakchi N et al. |
[Biochemical and pharmacologic properties of platelet aggregants and platelet antiaggregants of viper venoms in Tunisia]. |
1994 Jul-Oct |
Arch Inst Pasteur Tunis |
pmid:8801850
|
Subissi A et al. |
Octylonium bromide, an antagonist of platelet-activating factor. |
1989 Nov-Dec |
Arch Int Pharmacodyn Ther |
pmid:2636821
|
Yamada T et al. |
Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor. |
1990 Nov-Dec |
Arch Int Pharmacodyn Ther |
pmid:2099131
|
Damas J et al. |
Inhibition by WEB 2086, a PAG-acether antagonist of oedema and peritonitis induced by zymosan in rats. |
1990 Jul-Aug |
Arch Int Pharmacodyn Ther |
pmid:2076045
|
Damas J and Prunescu P |
Presence of immunoreactive platelet-activating factor in peritoneal exudate induced by zymosan in rats. |
1993 Mar-Apr |
Arch Int Pharmacodyn Ther |
pmid:8215712
|
Hemmendinger S et al. |
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. |
1985 |
Arch Mal Coeur Vaiss |
pmid:3938941
|
Jambou D et al. |
[Mediators of the vascular endothelium as markers of myocardial ischemia and reperfusion]. |
1993 |
Arch Mal Coeur Vaiss |
pmid:8304814
|
Gateau O |
[Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. |
1987 |
Arch Mal Coeur Vaiss |
pmid:3117010
|
Partrick DA et al. |
Maximal human neutrophil priming for superoxide production and elastase release requires p38 mitogen-activated protein kinase activation. |
2000 |
Arch Surg |
pmid:10668885
|
Kelly GL and Eiseman B |
Development of a new vascular prosthetic: lessons learned. |
1982 |
Arch Surg |
pmid:7125901
|
Arbabi S et al. |
Priming interleukin 8 production: role of platelet-activating factor and p38. |
1999 |
Arch Surg |
pmid:10593333
|
Emil S et al. |
Inhaled nitric oxide prevents experimental platelet activating factor-induced shock. |
1996 |
Arch Surg |
pmid:8712910
|
Biffl WL et al. |
Interleukin-6 potentiates neutrophil priming with platelet-activating factor. |
1994 |
Arch Surg |
pmid:7979944
|
Lo CJ et al. |
Endotoxin-induced macrophage gene expression depends on platelet-activating factor. |
1997 |
Arch Surg |
pmid:9403541
|
Fletcher JR |
Eicosanoids. Critical agents in the physiological process and cellular injury. |
1993 |
Arch Surg |
pmid:8239981
|
Thompson WA et al. |
The metabolic effects of platelet-activating factor antagonism in endotoxemic man. |
1994 |
Arch Surg |
pmid:8279943
|
Vadnais ML et al. |
Current concepts of molecular events during bovine and porcine spermatozoa capacitation. |
2007 May-Jun |
Arch. Androl. |
pmid:17612869
|
Jones RE |
Synthesis of ether lipids and phosphatidylethanolamine by ejaculated human spermatozoa. |
1997 May-Jun |
Arch. Androl. |
pmid:9140614
|
Ohtsuka T et al. |
Synergism between platelet-activating factor and diacylglycerol in the induction of superoxide anion production in guinea pig polymorphonuclear leukocytes. |
1990 |
Arch. Biochem. Biophys. |
pmid:2159756
|
Lee T et al. |
Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. |
2001 |
Arch. Biochem. Biophys. |
pmid:11368182
|
Furukawa M et al. |
Metabolic fate of platelet-activating factor in the rat enterocyte: the role of a specific lysophospholipase D. |
1995 |
Arch. Biochem. Biophys. |
pmid:7771795
|
Lekka M et al. |
Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol. |
1993 |
Arch. Biochem. Biophys. |
pmid:8489242
|
Shukla SD |
Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolin. |
1985 |
Arch. Biochem. Biophys. |
pmid:3875314
|
Chao W et al. |
Regulation of platelet-activating factor receptor and PAF receptor-mediated arachidonic acid release by protein kinase C activation in rat Kupffer cells. |
1990 |
Arch. Biochem. Biophys. |
pmid:2171429
|
Kajiyama Y et al. |
Pertussis toxin-sensitive GTP-binding proteins may regulate phospholipase A2 in response to thrombin in rabbit platelets. |
1989 |
Arch. Biochem. Biophys. |
pmid:2505676
|
Argyroudi-Akoyunoglou JH and Vakirtzi-Lemonias C |
Low-temperature fluorescence emission changes in thylakoids induced by acetyl glyceryl ether phosphorylcholine (AGEPC). |
1987 |
Arch. Biochem. Biophys. |
pmid:3813566
|
Zhou W and Olson MS |
A mechanism for phorbol ester-mediated regulation of the PAF receptor in human neutrophils. |
1994 |
Arch. Biochem. Biophys. |
pmid:8053680
|
Zhou W et al. |
Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation. |
1994 |
Arch. Biochem. Biophys. |
pmid:8109973
|
Heinsohn C et al. |
The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor. |
1987 |
Arch. Biochem. Biophys. |
pmid:3662526
|
Tokumura A et al. |
Alkylacetylglycerophosphocholine effects on the metabolism of phospholipids in rabbit platelets: effects of extracellular Ca2+ and prostacyclin. |
1986 |
Arch. Biochem. Biophys. |
pmid:3013094
|
Satouchi K et al. |
Metabolism of 1-O-alkyl-2-acetyl-sn-glycerol by washed rabbit platelets: formation of platelet activating factor. |
1984 |
Arch. Biochem. Biophys. |
pmid:6486825
|
Homma H et al. |
Some unique features of the metabolic conversion of platelet-activating factor (AGEPC) to alkyl acyl PC by washed rabbit platelets. |
1987 |
Arch. Biochem. Biophys. |
pmid:3101596
|
Shukla SD and Hanahan DJ |
Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion. |
1984 |
Arch. Biochem. Biophys. |
pmid:6465886
|
Svetlov SI et al. |
Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation. |
1996 |
Arch. Biochem. Biophys. |
pmid:8615681
|
Argyroudi-Akoyunoglou JH and Vakirtzi-Lemonias C |
Enhancement of chlorophyll a fluorescence yield, low-temperature F685/F730 fluorescence emission ratio, and electron transport rate by ether phospholipids (platelet activating factor and analogs) in isolated chloroplasts. |
1989 |
Arch. Biochem. Biophys. |
pmid:2817899
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+. |
1984 |
Arch. Biochem. Biophys. |
pmid:6430234
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Eguchi H et al. |
Binding and metabolism of platelet-activating factor (PAF) by isolated rat type II pneumonocytes. |
1994 |
Arch. Biochem. Biophys. |
pmid:8109971
|
Vallari DS et al. |
Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator. |
1990 |
Arch. Biochem. Biophys. |
pmid:2154953
|
Kumar R et al. |
Occurrence of platelet-activating factor in rabbit spermatozoa. |
1988 |
Arch. Biochem. Biophys. |
pmid:3341753
|
Huo YN et al. |
A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. |
1988 |
Arch. Biochem. Biophys. |
pmid:3341767
|
Nunez D et al. |
Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets. |
1989 |
Arch. Biochem. Biophys. |
pmid:2502069
|
Lee TC et al. |
Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway. |
1983 |
Arch. Biochem. Biophys. |
pmid:6407399
|
Homma H and Hanahan DJ |
Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. |
1988 |
Arch. Biochem. Biophys. |
pmid:2833174
|
Toyoshima K et al. |
Coenzyme A-independent transacylation in amnion-derived (WISH) cells. |
1994 |
Arch. Biochem. Biophys. |
pmid:7944398
|
Ihara Y et al. |
Hormonal regulation of platelet-activating factor-acetyltransferase activity in rat tissues. |
1993 |
Arch. Biochem. Biophys. |
pmid:8346925
|
Sanwick JM et al. |
Human spermatozoa produce C16-platelet-activating factor. |
1992 |
Arch. Biochem. Biophys. |
pmid:1575513
|
Hwang SB |
Specific receptor sites for platelet activating factor on rat liver plasma membranes. |
1987 |
Arch. Biochem. Biophys. |
pmid:2821908
|
Browne PC et al. |
Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. |
1988 |
Arch. Biochem. Biophys. |
pmid:2844122
|
Pieroni G and Hanahan DJ |
Metabolic behavior of acetyl glyceryl ether phosphorylcholine on interaction with rabbit platelets. |
1983 |
Arch. Biochem. Biophys. |
pmid:6870274
|
Sugiura T et al. |
Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor. |
1994 |
Arch. Biochem. Biophys. |
pmid:8203898
|